Patent details

EP2408454 Title: NOVEL ANTI-INFLAMMATORY AGENTS

  • Data
  • Documents

Basic Information

Publication number:
EP2408454
PCT Application Number:
IB2010000826
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP107160483
PCT Publication Number:
WO2010106436
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL ANTI-INFLAMMATORY AGENTS
French Title of Invention:
NOUVEAUX AGENTS ANTI-INFLAMMATOIRES
German Title of Invention:
NEUE ENTZÜNDUNGSHEMMENDE MITTEL
SPC Number:

Dates

Filing date:
16/03/2010
Grant date:
24/07/2024
EP Publication Date:
25/01/2012
PCT Publication Date:
23/09/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/07/2024
EP B1 Publication Date:
24/07/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
16/03/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/07/2024
 
 

Name:
Resverlogix Corp.
Address:
300, 4820 Richard Road SW, Calgary, AB T3E 6L1, Canada (CA)

Inventor

Name:
HANSEN, C., Henrik
Address:
Canada (CA)

Priority

Priority Number:
161089 P
Priority Date:
18/03/2009
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/517; A61P 9/00; C07D 471/04; C07D 409/10; C07D 239/88; A61K 31/55; C07D 417/06; C07D 403/12; C07D 403/10; C07D 401/12; C07D 401/10; C07D 401/04; A61K 31/551; A61K 31/5377; A61K 31/519; C07D 403/04; C07D 409/12; C07D 239/91; C07D 401/14;

Publication

European Patent Bulletin

Issue number:
202430
Publication date:
24/07/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/09/2025
Annual Fee Number:
16
Annual Fee Amount:
230 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer: